IP Library › Assignment 023720/0296
Patent Assignment
Reel/Frame 023720/0296

Assignment of Assignor's Interest

Recorded: 2009-12-31 Pages: 13
Assignor
Assignee
WAGNER, THOMAS E.
104 GOLDEN WINGS WAY, GREENVILLE, SOUTH CAROLINA, 29650
Covered Properties (14)
Hybrid Cells
Patent: 6,849,451 →
Application: 09/756,293 →
Publication: US 2001/0049142
Therapeutic Pore-Forming Peptides
Patent: 7,094,750 →
Application: 09/851,422 →
Publication: US 2002/0077454
Lytic Peptide Prodrugs
Patent: 7,456,146 →
Application: 09/938,623 →
Publication: US 2002/0045736
Monocyte-Specific Particulate Delivery Vehicle
Patent: 6,875,612 →
Application: 10/112,036 →
Publication: US 2002/0155609
Stable Episomal Vectors
Patent: 7,294,505 →
Application: 10/231,467 →
Publication: US 2003/0064472
Vegf Receptor Antagonists
Patent: 7,582,726 →
Application: 10/985,013 →
Publication: US 2005/0196396
Therapeutic Pore-Forming Peptides
Patent: 7,425,535 →
Application: 11/123,182 →
Publication: US 2005/0267031
Acetylated Therapeutic Procytotoxins
Patent: 7,550,426 →
Application: 11/131,443 →
Publication: US 2006/0264364
Combination therapy of hybrid cells with BCG injection for treating Cancer Patients
Application: 11/802,566 →
Publication: US 2009/0087450
Polypeptides Comprising Fas Activation and NKG2D-Ligand Domains
Patent: 7,777,004 →
Application: 11/945,747 →
Publication: US 2008/0242610
Activation of nuclear factor kappa B
Application: 12/149,086 →
Publication: US 2009/0081789
Macrophage transfection method
Application: 12/149,097 →
Publication: US 2009/0117658
Compositions and methods for inducing tumor resistance
Application: 12/320,214 →
Publication: US 2009/0246230
Hybrid Cells for Treating Cancer Patients
Patent: 8,785,186 →
Application: 12/461,760 →
Publication: US 2010/0047288
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 14, 2014
From: WAGNER, THOMAS E.
To: ORBIS HEALTH SOLUTIONS LLC
Reel/Frame 032665/0086 →